2-170815568-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000663207.2(ERICH2-DT):​n.1256G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.285 in 152,002 control chromosomes in the GnomAD database, including 6,993 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6993 hom., cov: 31)

Consequence

ERICH2-DT
ENST00000663207.2 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.409

Publications

7 publications found
Variant links:
Genes affected
ERICH2-DT (HGNC:55686): (ERICH2 divergent transcript)
GAD1 (HGNC:4092): (glutamate decarboxylase 1) This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form. [provided by RefSeq, Jul 2008]
GAD1 Gene-Disease associations (from GenCC):
  • early infantile epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy 89
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 1
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.486 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAD1-AS1NR_197761.1 linkn.1561G>C non_coding_transcript_exon_variant Exon 4 of 4
GAD1-AS1NR_197762.1 linkn.1330G>C non_coding_transcript_exon_variant Exon 3 of 3
GAD1-AS1NR_197763.1 linkn.1387G>C non_coding_transcript_exon_variant Exon 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERICH2-DTENST00000663207.2 linkn.1256G>C non_coding_transcript_exon_variant Exon 2 of 2
ERICH2-DTENST00000729370.1 linkn.395G>C non_coding_transcript_exon_variant Exon 2 of 2
GAD1ENST00000454603.5 linkc.-64+2146C>G intron_variant Intron 1 of 3 4 ENSP00000402366.1

Frequencies

GnomAD3 genomes
AF:
0.284
AC:
43205
AN:
151884
Hom.:
6985
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.120
Gnomad AMI
AF:
0.306
Gnomad AMR
AF:
0.352
Gnomad ASJ
AF:
0.294
Gnomad EAS
AF:
0.502
Gnomad SAS
AF:
0.390
Gnomad FIN
AF:
0.337
Gnomad MID
AF:
0.282
Gnomad NFE
AF:
0.336
Gnomad OTH
AF:
0.304
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.285
AC:
43245
AN:
152002
Hom.:
6993
Cov.:
31
AF XY:
0.288
AC XY:
21413
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.120
AC:
4988
AN:
41472
American (AMR)
AF:
0.352
AC:
5376
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
1018
AN:
3466
East Asian (EAS)
AF:
0.503
AC:
2588
AN:
5150
South Asian (SAS)
AF:
0.391
AC:
1882
AN:
4818
European-Finnish (FIN)
AF:
0.337
AC:
3555
AN:
10556
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.336
AC:
22832
AN:
67960
Other (OTH)
AF:
0.304
AC:
643
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1510
3020
4530
6040
7550
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.174
Hom.:
390
Bravo
AF:
0.279
Asia WGS
AF:
0.429
AC:
1486
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.75
DANN
Benign
0.60
PhyloP100
-0.41

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3762556; hg19: chr2-171672078; API